Allogene Therapeutics Stock Performance
as on September 19, 2026 at 2:15 pm IST
Day's Low
Day's High
$1.67$1.72
1.18%
Downside
1.78%
Upside
52 Week's Low
52 Week's High
$1.04$4.4638.46%
Downside
163.91%
Upside
Allogene Therapeutics share price movements today
- Previous Close
- $1.73
- Open
- $1.72
- Volume
- 5.0M
- Market Cap
- $597.7M
- Day's Low - High
- $1.67 - $1.72
- 52 Week Low - High
- $1.04 - $4.46
Allogene Therapeutics Historical Returns
- 1 Month Return
- -22.42 %
- 3 Month Return
- -13.5 %
- 1 Year Return
- + 49.14 %
- 3 Year Return
- -55.75 %
- 5 Year Return
- -93.18 %
Allogene Therapeutics Stock Fundamentals & Key Indicators
Check Allogene Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$597.7M
EPS (TTM)
-0.67
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.57
Industry PE ratio
-6.87
PEG Ratio
-0.045417473574662866
EBITDA
-152.5M
Revenue (TTM)
4.6M
Profit Margin
-699.35%
Return On Equity TTM
-50.04%
Allogene Therapeutics Stock Valuation
Track how Allogene Therapeutics P/E has moved over time to understand its valuation trends.
Allogene Therapeutics in the last 5 years
Lowest (-11.13x)
December 31, 2021
Industry (-6.87x)
December 31, 2025
Today (-1.57x)
December 31, 2025
Highest (-1.54x)
December 31, 2023
Today’s Price to Earnings Ratio: -1.57x
Allogene Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Allogene Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $597.7M | -93.18% | -2.57 | -699.35% | 0.00% | |
| BUY | $63.1B | -63.24% | -19.81 | -12.57% | 0.00% | |
| BUY | $130.1B | 174.21% | 29.81 | 86.04% | 0.00% | |
| BUY | $79.7B | 21.1% | 18.48 | 84.86% | 0.48% |
Stock Returns calculator for Allogene Therapeutics Stock including INR - Dollar returns
The Allogene Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Allogene Therapeutics investment value today
Current value as on today
₹1,58,555
Returns
₹58,555
(+58.56%)
Returns from Allogene Therapeutics Stock
₹45,690 (+45.69%)
Dollar Impact
₹12,866 (+12.87%)
Analyst Recommendation on Allogene Therapeutics Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71428571428571% of analysts recommend a 'BUY' rating for Allogene Therapeutics. Average target price of $9
Allogene Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Allogene Therapeutics.
What analysts predicted
81.22%UPSIDE
Target Price
$9
Current Price
$1.69
Analyzed by
7 Analysts
Target
$9.00
Allogene Therapeutics target price $9, a slight upside of 81.22% compared to current price of $1.69. According to 7 analysts rating.
Indian Investors' Interest in Allogene Therapeutics Stock
Search interest for Allogene Therapeutics Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Allogene Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Allogene Therapeutics Annual Profit & Loss
All numbers in Millions USD
Allogene Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Allogene Therapeutics Annual Cash Flow
All numbers in Millions USD
Allogene Therapeutics News & Key Events
Today's Timeline - 02 September
Wed, 06:15 PM
-CFO Geoffrey Parker announces retirement effective November 6, 2026, while continuing to lead finance until a successor is found.
Insights on Allogene Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, -22.0K → 4.64M (in $), with an average increase of 100.5% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 464.6%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 44.3% return, outperforming this stock by 101.1%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, -38.80M → -42.67M (in $), with an average decrease of 5.0% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, ALLO stock has moved down by -24.2%
About Allogene Therapeutics
| Organisation | Allogene Therapeutics |
| Headquarters | 210 East Grand Avenue, South San Francisco, CA, United States, 94080 |
| Industry | Biotechnology |
| CEO | Dr. Zachary J. Roberts M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Allogene Therapeutics
Name | Title |
|---|---|
Mr. Geoffrey M. Parker | Executive VP & CFO |
Ms. Christine Cassiano | Executive VP, Chief Corporate Affairs & Brand Strategy Officer |
Dr. David D. Chang M.D., Ph.D. | Co-Founder & Director |
Dr. Zachary J. Roberts M.D., Ph.D. | President, CEO & Director |
Mr. Joshua A. Kazam | Co-Founder & Director |
Mr. Benjamin M. Beneski | Senior VP & Chief Technical Officer |
Mr. Earl M. Douglas Esq. | Senior VP, General Counsel, Compliance Officer & Corporate Secretary |
Ms. Susan R. Lundeen | Chief People Officer |
Ms. Annie Yoshiyama | SVP & Corporate Controller |
Dr. Arie S. Belldegrun F.A.C.S., M.D. | Co-Founder & Executive Chairman |
FAQs
What is Allogene Therapeutics share price today?
Allogene Therapeutics share price today is $1.69 as on at the close of the market. Allogene Therapeutics share today touched a day high of $1.72 and a low of $1.67.
What is the 52 week high and 52 week low for Allogene Therapeutics share?
Allogene Therapeutics share touched a 52 week high of $4.46 on and a 52 week low of $1.04 on . Allogene Therapeutics stock price today i.e. is closed at $1.69,which is 62.11% down from its 52 week high and 62.50% up from its 52 week low.
What is Allogene Therapeutics's market capitalisation today?
Allogene Therapeutics market capitalisation is $0.00T as on .
How to invest in Allogene Therapeutics Stock (ALLO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Allogene Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Allogene Therapeutics Shares that will get you 0.8876 shares as per Allogene Therapeutics share price of $1.69 per share as on September 19, 2026 at 8:45 am IST.
What is the minimum amount required to buy Allogene Therapeutics Stock (ALLO) from India?
Indian investors can start investing in Allogene Therapeutics (ALLO) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Allogene Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Allogene Therapeutics share’s latest price of $1.69 as on September 19, 2026 at 8:45 am IST, you will get 5.9172 shares of Allogene Therapeutics. Learn more about
fractional shares .
What are the returns that Allogene Therapeutics has given to Indian investors in the last 5 years?
Allogene Therapeutics stock has given -93.18% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?